Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.55 |
| ▸ | CA2 | P00918 | 4/20 | 0.55 |
| ▸ | CA12 | O43570 | 3/20 | 0.55 |
| ▸ | CA7 | P43166 | 3/20 | 0.55 |
| ▸ | CA9 | Q16790 | 3/20 | 0.55 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.55 |
| ▸ | ESR1 | P03372 | 5/20 | 0.55 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.55 |
| ▸ | SENP1 | Q9P0U3 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | KDR | P35968 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17826636 | 0.94 | SENP1 (0.59) | CA1CA2CA12CA7CA9 | |
| SCHEMBL18594949 | 0.94 | NPC1 (0.54) | CA1CA2CA12CA7CA9 | |
| SCHEMBL15482301 | 0.90 | KMT2A (0.57) | CA1CA2CA12CA7CA9 | |
| SCHEMBL15591334 | 0.86 | ESR2 (0.56) | CA1CA2CA12CA7CA9 | |
| SCHEMBL16351760 | 0.86 | TDP1 (0.57) | ESR1ESR2MEN1KMT2APOLB | |
| SCHEMBL1816359 | 0.84 | ALDH1A1 (0.50) | CA1CA2CA12CA7CA9 | |
| SCHEMBL16234552 | 0.83 | KMT2A (0.58) | CA1CA2CA12CA7CA9 | |
| SCHEMBL767990 | 0.83 | CA12 (0.50) | CA1CA2CA12CA7CA9 | |
| SCHEMBL777892 | 0.83 | KMT2A (0.52) | ESR1ESR2SENP1MEN1KMT2A | |
| SCHEMBL13560668 | 0.82 | ALDH1A1 (0.53) | CA1CA2CA12CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230012512-A1 | VIEWING ANGLE CONTROL SYSTEM AND IMAGE DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2023-01-19 | — | — | US | disclosed |
| US-20220171212-A1 | OPTICAL LAMINATE, METHOD OF MANUFACTURING PATTERNED OPTICAL ANISOTROPIC LAYER, 3D IMAGE DISPLAY APPARATUS, AND 3D IMAGE DISPLAY | FUJIFILM CORPORATION (JP) | 2022-06-02 | — | — | US | disclosed |
| US-10935836-B2 | Organic electroluminescent display device, phase difference film, and circularly polarizing plate | FUJIFILM CORPORATION (JP) | 2021-03-02 | — | — | US | disclosed |
| US-20210026049-A1 | OPTICAL ELEMENT | FUJIFILM CORPORATION (JP) | 2021-01-28 | — | — | US | disclosed |
| US-10854852-B2 | Organic EL image display device | FUJIFILM CORPORATION (JP) | 2020-12-01 | — | — | US | disclosed |
| US-20200363682-A1 | IMAGE DISPLAY DEVICE AND CIRCULARLY POLARIZING PLATE WITH PHOTOSENSITIVE ADHESIVE | FUJIFILM CORPORATION (JP) | 2020-11-19 | — | — | US | disclosed |
| US-20200075896-A1 | ORGANIC EL IMAGE DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2020-03-05 | — | — | US | disclosed |
| US-20190353957-A1 | ORGANIC ELECTROLUMINESCENT DISPLAY DEVICE, PHASE DIFFERENCE FILM, AND CIRCULARLY POLARIZING PLATE | FUJIFILM CORPORATION (JP) | 2019-11-21 | — | — | US | disclosed |
| US-9759945-B2 | Circular polarizing plate having patterned retardation layer and organic EL display element having said circular polarizing plate | FUJIFILM CORPORATION (JP) | 2017-09-12 | — | — | US | disclosed |
| US-8404794-B2 | Liquid crystal compositions | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-03-26 | — | — | US | disclosed |
| US-7879256-B2 | bis(meth)acrylates with esters linking mesogen to a flexible spacer and polymerizable (meth)acrylates | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-02-01 | — | — | US | disclosed |
| US-20100308265-A1 | LIQUID CRYSTAL COMPOSITIONS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-12-09 | — | — | US | disclosed |
| US-20100308265-A1 | LIQUID CRYSTAL COMPOSITIONS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-12-09 | — | — | US | disclosed |
| US-20100308269-A1 | LIQUID CRYSTAL COMPOSITIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-12-09 | — | — | US | disclosed |
| US-20100308269-A1 | LIQUID CRYSTAL COMPOSITIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-12-09 | — | — | US | disclosed |
| US-20100308270-A1 | LIQUID CRYSTAL COMPOSTIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-12-09 | — | — | US | disclosed |
| US-20100308270-A1 | LIQUID CRYSTAL COMPOSTIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-12-09 | — | — | US | disclosed |
| US-20100308268-A1 | LIQUID CRYSTAL COMPOSITIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-12-09 | — | — | US | disclosed |
| US-20100308268-A1 | LIQUID CRYSTAL COMPOSITIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-12-09 | — | — | US | disclosed |
| WO-2007049779-A1 | CELLULOSE COMPOUND COMPOSITION AND CELLULOSE COMPOUND FILM | FUJIFILM CORPORATION (JP) | 2007-05-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100308265-A1 | LIQUID CRYSTAL COMPOSITIONS | CNOT9, AQP3, AQP1 | CA1 411/4885CA2 1498/4885CA12 744/4885 |
| US-20100308270-A1 | LIQUID CRYSTAL COMPOSTIONS | TTR, CNOT9, CNOT7 | CA1 39/4885CA2 712/4885CA12 287/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.